TENKASI 1200 mg / 1200 mg / 1 flacon(s)
7680681350026
CH-68135
J01XA05
08.01.9.
Reimbursement limitations:
TENKASI.01
Pour le traitement d’infections bactériennes aiguës de la peau et des tissus mous (IBAPTM) chez …
1 / 2
google
Details
- Product number
- 6813502
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio sicca: oritavancinum 1200 mg ut oritavancini diphosphas, hydroxypropylbetadexum 2400 mg, mannitolum, acidum phosphoricum q.s. ad pH, natrii hydroxidum q.s. ad pH, pro vitro.
Articles (1)
Tenkasi 1200 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRS
|
1200.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRS
|
- | Substance | WIZUS |
|
PRS
|
2400.0 MG | Substance | HBESI |
|
PRS
|
- | Substance | HNIDK |
|
PRS
|
- | Substance | HNIDK |
|
PRS
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 2260.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2025
Authorization holder
A. Menarini GmbH
8050 Zürich
Authorization information
- Swissmedic authorization number
- 68135
- Drug name
- Tenkasi, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- J01XA05
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 07/04/2022
- Authorization expiration date
- 06/04/2027
- IT number
- 08.01.9.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TENKASI 1200 mg / 1200 mg / 1 flacon(s)
- Description (DE)
- TENKASI 1200 mg / 1200 mg / 1 Durchstechflasche(n)
- Market launch
- 01/06/2025
- Narcotic (BTM)
- No